The treatment also led to a decrease in Ki67 levels, a marker of tumor proliferation, and reduced phosphorylation of RB1, reinforcing the drug's efficacy in inhibiting the CDK4/CDK6-RB1 axis in ESCC.

Get inspired to transform your live-cell assays Accurately counting viable cells in a sample is crucial for various biological assays, including normalization and assessing drug impacts on cell ...

Insights into the many facets of cell death, particularly cancer cell evasion mechanisms, are therefore critical to unlock new avenues for treatments. Agilent presents a fully automated, kinetic ...